Priority Date: 14.06.16 (US 201662349888P)

ANTI-COAGULATION FACTOR XI ANTIBODIES

  • Application ID: EP17731444
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 229 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2016 - Priority Date (US 201662349888P)
  • 21.12.2017 - Publication A1 (WO2017218371)
  • 17.04.2019 - Publication A1 (EP3469002)

IPC Classification